DPH.L - Dechra Pharmaceuticals PLC

LSE - LSE Delayed price. Currency in GBp
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Total revenue
498,900
481,800
407,100
359,275
247,562
Cost of revenue
213,300
208,700
184,700
167,560
115,122
Gross profit
285,600
273,100
222,400
191,715
132,440
Operating expenses
Research development
26,200
25,100
18,300
26,419
10,355
Selling general and administrative
130,800
125,700
110,000
99,613
75,298
Total operating expenses
233,800
227,600
182,400
155,035
105,802
Operating income or loss
51,800
45,500
40,000
36,680
26,638
Interest expense
10,900
10,500
6,900
5,056
2,389
Income before tax
38,300
27,800
28,900
28,562
14,548
Income tax expense
9,700
-3,100
-7,200
2,452
2,036
Income from continuing operations
28,600
30,900
36,100
26,110
12,512
Net income
28,600
30,900
36,100
26,105
12,668
Net income available to common shareholders
28,600
30,900
36,100
26,105
12,668
Basic EPS
-
0.30
0.37
0.28
0.14
Diluted EPS
-
0.30
0.37
0.28
0.14
Basic average shares
-
102,505
96,942
92,963
89,380
Diluted average shares
-
102,762
97,451
93,479
90,009
EBITDA
-
115,100
89,900
62,621
42,252
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more